Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 30, 2015 07:30 ET | Source: uniQure

uniQure Announces Financial Results for Third Quarter 2015 and Provides Update on Product Pipeline and Company Developments

AMSTERDAM, the Netherlands, Nov. 30, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced financial results for the third quarter and nine months...
November 23, 2015 05:35 ET | Source: uniQure

uniQure Announces Conference Call and Webcast to Discuss Third Quarter Financial Results and Corporate Update

AMSTERDAM, the Netherlands, Nov. 23, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that the Company will release its financial results and a...
November 12, 2015 05:58 ET | Source: uniQure

uniQure to Present at the Jefferies 2015 Global Healthcare Conference - London

AMSTERDAM, the Netherlands, Nov. 12, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that its management will present at the Jefferies 2015 Global...
October 07, 2015 08:46 ET | Source: uniQure

uniQure to Host Investor Day in New York City on October 15, 2015

AMSTERDAM, the Netherlands, Oct. 7, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that it will be hosting an Investor Day and simultaneous...
September 19, 2015 08:12 ET | Source: uniQure

Positive Topline Results Announced From Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure's Novel AAV5-Based Gene Therapy

--Safety, Durable NaGlu Protein Expression and Positive Signs of Efficacy Demonstrated in All Four Patients-- --First Clinical Validation of AAV5 Vector Effectively Delivering Target Gene into the...
September 01, 2015 08:59 ET | Source: uniQure

uniQure to Present at NewsMakers in the Biotech Industry Conference - NYC

AMSTERDAM, Netherlands, Sept. 1, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that its management will present at the NewsMakers in the Biotech...
August 27, 2015 05:05 ET | Source: uniQure

uniQure Announces Financial Results for Second Quarter 2015

AMSTERDAM, the Netherlands, Aug. 27, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced financial results for the second quarter and six months...
August 10, 2015 05:00 ET | Source: uniQure

uniQure Announces Receipt of $53 Million From Bristol-Myers Squibb for Target Selection Payment and Additional Equity Investment

AMSTERDAM, the Netherlands, Aug. 10, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced the receipt of an additional $53 million from Bristol-Myers...
July 16, 2015 05:00 ET | Source: uniQure

Dr. Charles W. Richard Joins uniQure as Senior Vice President to Lead Development of CNS-focused Gene Therapy Pipeline

AMSTERDAM, the Netherlands, July 16, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that Charles W. Richard, M.D., Ph.D., has been hired as Senior...
June 11, 2015 05:52 ET | Source: uniQure

uniQure Announces Financial Results for First Quarter 2015

AMSTERDAM, The Netherlands, June 11, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced financial results for the first quarter ending March 31, 2015,...